Identification of a prenatal profile of Cornelia de Lange syndrome (CdLS): A review of 53 CdLS pregnancies

• Published in: American journal of medical genetics. Part A 2012-08, Vol.158A (8), p.1848-1856
• Main Authors: Clark, Dinah M., Sherer, Ilana, Deardorff, Matthew A., Byrne, Janice L.B., Loomes, Kathleen M., Nowaczyk, Malgorzata J.M., Jackson, Laird G., Krantz, Ian D.
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Cognitive ability; Cornelia de Lange syndrome; De Lange Syndrome - diagnosis; De Lange Syndrome - physiopathology; Female; Humans; IUGR; Malformations of the nervous system; Medical genetics; Medical sciences; Neurology; PAPP-A; Pregnancy; Prenatal Diagnosis; prenatal screening
• ISSN: 1552-4825; 1552-4833
• DOI: 10.1002/ajmg.a.35410

Cornelia de Lange Syndrome (CdLS) is a multisystem developmental disorder characterized by growth retardation, cognitive impairment, external and internal structural malformations, and characteristic facial features. Currently, there are no definitive prenatal screening measures that lead to the diagnosis of CdLS. In this study, documented prenatal findings in CdLS syndrome were analyzed towards the development of a prenatal profile predictive of CdLS. We reviewed 53 cases of CdLS (29 previously reported and 24 unreported) in which prenatal observations/findings were available. The review of these cases revealed a pattern of sonographic findings, including obvious associated structural defects, growth restriction, as well as a more subtle, but strikingly characteristic, facial profile, and suggestive of a recognizable prenatal ultrasonographic profile for CdLS. In addition, the maternal serum marker, PAPP‐A, may be reduced and fetal nuchal translucency (NT) may be increased in some pregnancies when measured at an appropriate gestational age. In conclusion, CdLS can be prenatally diagnosed or readily ruled out in a family with a known mutation in a CdLS gene. The characteristic ultrasonographic profile may allow for prenatal diagnosis of CdLS in (1) subsequent pregnancies to a couple with a prior child with CdLS in whom a mutation has not been identified or (2) when there are unexplained pregnancy signs of fetal abnormality, such as oligo‐ or polyhydramnios, a low maternal serum PAPP‐A level and/or increased NT, fetal growth retardation, or structural anomalies consistent with CdLS. © 2012 Wiley Periodicals, Inc.